LDN-212854 is a bone morphogenetic protein (BMP) inhibitor that potently inhibits ALK2 (IC50: 1.3 nM). LDN-212854 also inhibits ALK1 (IC50: 2.40 nM). LDN-212854 can be used in the research of fibrodysplasia ossificans progressive and cancers, such as hepatocellular carcinoma (HCC)[1][2].
Molecular Weight:
406.48
Purity:
99.70
CAS Number:
[1432597-26-6]
Formula:
C25H22N6
Target:
TGF-beta Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted